NCT03182972

Brief Summary

This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2016

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 8, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 9, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
Last Updated

November 30, 2022

Status Verified

November 1, 2022

Enrollment Period

2.7 years

First QC Date

June 8, 2017

Last Update Submit

November 25, 2022

Conditions

Keywords

intervention studymedication reconciliationpharmacistsNigeriaDiabetesHypertension

Outcome Measures

Primary Outcomes (1)

  • Medication reconciliation: Percentage unreconciled medications

    Percentage unreconciled medications

    3 months

Study Arms (2)

Intervention arm

EXPERIMENTAL

Seminar presentation will be done using the followings: 1. Power point presentation on the following topics as it relates to medication reconciliation: 1. Communication skill (with patients and also with other members of the healthcare team) 2. Documentation of pharmaceutical care activities 3. Medication history taking 4. Drug therapy problems 5. Medication reconciliation practice 2. Case studies on medication reconciliation 3. Role plays on medication reconciliation

Other: Medication reconciliation

Control arm

NO INTERVENTION

Control group

Interventions

Pre-post intervention

Intervention arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant has diabetes and/or hypertension
  • Registered pharmacists in the selected institutions

You may not qualify if:

  • Participants that are neither diabetic nor hypertensive
  • Unregistered pharmacists in the selected institutions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Ilorin Teaching Hospital

Ilorin, Kwara State, Nigeria

Location

University College Hospital

Ibadan, Oyo State, 2334, Nigeria

Location

MeSH Terms

Conditions

Diabetes MellitusHypertension

Interventions

Medication Reconciliation

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Medication ErrorsDrug TherapyTherapeuticsMedical ErrorsHealth ServicesHealth Care Facilities Workforce and ServicesMedication SystemsOrganization and AdministrationHealth Services AdministrationPatient Care Management

Study Officials

  • TITILAYO O FAKEYE, PhD

    University of Ibadan

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Both the patients and the pharmacists recruited for the study will not be informed whether they are in the control or intervention group
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: University College Hospital, Ibadan will serve as the intervention group while University of Ilorin Teaching Hospital, Ilorin will serve as the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer II

Study Record Dates

First Submitted

June 8, 2017

First Posted

June 9, 2017

Study Start

August 2, 2016

Primary Completion

April 30, 2019

Study Completion

April 30, 2019

Last Updated

November 30, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share

Locations